淳中科技(603516.SH):2019年激勵計劃第一期解除限售條件成就及第一個行權期符合行權條件
格隆匯2月22日丨淳中科技(603516.SH)公佈,公司2019年股票期權與限制性股票激勵計劃限制性股票第一期解除限售條件及期權第一個行權期行權條件已滿足。限制性股票計劃中1名激勵對象因離職不符合解除限售條件,其餘66名激勵對象限制性股票第一期解除限售條件成就,可獲授68.55萬股限制性股票;股票期權激勵對象中11名激勵對象因離職不符合行權條件,其餘91名激勵對象股票期權第二個行權期行權條件成就,可獲授35.79萬份股票期權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.